<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00420108</url>
  </required_header>
  <id_info>
    <org_study_id>06U.232</org_study_id>
    <nct_id>NCT00420108</nct_id>
  </id_info>
  <brief_title>Optivol Diagnostic Data for Discharge in Heart Failure</brief_title>
  <acronym>3DHF</acronym>
  <official_title>Comparing ICD Device Diagnostics to Hospitalized Heart Failure Patient Symptoms and Physician Opinion on Discharge Readiness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate whether the heart rate variability, daily heart&#xD;
      rate, and/or intrathoracic impedance recorded by implantable cardiac devices can be used in&#xD;
      conjunction with other traditional clinical practice methods to determine if heart failure&#xD;
      patients are ready for hospital discharge.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantable cardioverter defibrillator (ICD) devices with or without cardiac&#xD;
      resynchronization therapy (CRT-D) have the ability to continuously monitor heart rate&#xD;
      variability, daily heart rate, and patient activity. Changes in these measures have been&#xD;
      associated with heart failure prognosis. In addition, ICD or CRT-D devices also have the&#xD;
      ability to measure daily intrathoracic impedance. Previous data have demonstrated that&#xD;
      device-based intrathoracic impedance measurements correlate with pulmonary capillary wedge&#xD;
      pressure and fluid retention, both of which are common measures of heart failure status. The&#xD;
      objective of this study is to evaluate whether the heart rate variability, daily heart rate,&#xD;
      and/or intrathoracic impedance can be used in conjunction with other methods to determine if&#xD;
      patients are ready for hospital discharge. This will be the first step in potentially&#xD;
      developing an inpatient care strategy which includes implantable device data. It is&#xD;
      hypothesized that device diagnostic data will identify an appropriate and safe time to&#xD;
      discharge patients admitted for worsening heart failure symptoms before usual clinical&#xD;
      indicators. More specifically, we hypothesize that device data will &quot;normalize&quot; at least one&#xD;
      day prior to the clinical indicators of readiness for discharge and patients discharged prior&#xD;
      to &quot;normalization&quot; of the device data will be at greater risk for rehospitalization&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">23</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <condition>Cardiac Pacemaker, Artificial</condition>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      No biospecimens to be retained&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is hospitalized patients who have an implanted Medtronic device with&#xD;
        Optivol capability.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients implanted with a Medtronic InSync Sentry or subsequent FDA-approved Medtronic&#xD;
             device with the OptiVol capability for &gt;30 days.&#xD;
&#xD;
          -  Anticipated hospitalization stay &gt;48 hours&#xD;
&#xD;
          -  Hospitalized patients experiencing worsening heart failure with symptoms of&#xD;
             lung/pulmonary congestion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Anemia - admission hemoglobin &lt;8.0 g/dL&#xD;
&#xD;
          -  Patients residing in convalescence center prior to admission or known to be discharged&#xD;
             to a convalescence center or hospice, where discharge could be based on bed&#xD;
             availability&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J Whellan, MD MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heartland Health</name>
      <address>
        <city>St. Joseph</city>
        <state>Missouri</state>
        <zip>64506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of Delaware Valley</name>
      <address>
        <city>Elmer</city>
        <state>New Jersey</state>
        <zip>083618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Main Line Health Lankenau Hospital</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <study_first_submitted>January 8, 2007</study_first_submitted>
  <study_first_submitted_qc>January 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2007</study_first_posted>
  <last_update_submitted>August 18, 2010</last_update_submitted>
  <last_update_submitted_qc>August 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Office of Research Administration</name_title>
    <organization>Thomas Jefferson University</organization>
  </responsible_party>
  <keyword>Heart Failure, Congestive</keyword>
  <keyword>Cardiac Pacemaker, Artificial</keyword>
  <keyword>Ventricular Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

